PerkinElmer to purchase remaining interest of ICP-MS joint venture from Danaher

PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced that it has agreed to purchase the remaining interest of its joint venture in Inductively Coupled Plasma Mass Spectrometry (ICP-MS) and related assets from Danaher Corporation. Danaher acquired this joint venture stake and these assets as part of its acquisition of MDS Inc.’s Analytical Technologies business.

The purchase of the remaining 50% of the joint venture and related assets will provide PerkinElmer with full ownership of the joint venture and its ICP-MS product line. Complete PerkinElmer ownership of the ICP-MS product line and related assets will help to ensure the continued success of this technology with a dedicated and fully integrated approach throughout the entire value chain, including R&D, manufacturing, sales and service.

John Roush, president, Environmental Health, PerkinElmer, said, “The global population is increasingly vulnerable to safety threats from toxic elements such as lead, cadmium, mercury, and arsenic affecting the quality of our water and food supplies. Our continued commitment and innovation in ICP-MS will provide our customers with solutions that support the analysis of component elements, trace elements or contaminants in samples of interest, leading to improved products and applications for their end markets – and ultimately to better outcomes for human and environmental health."

He added, "The consolidation of the joint venture will reinforce our market leadership position while further demonstrating our commitment to the ICP-MS product line and the sustained development of this critical technology. Customers will benefit from our ability to get products to market faster, as well as to better align our offering with market needs.”

ICP-MS is a detection technology that allows high-sensitivity simultaneous detection of individual chemical elements in a sample, for diverse applications within the environmental, nutraceutical, biomonitoring, semiconductor and geochemical research markets.

PerkinElmer has been at the forefront of atomic spectroscopy analytical technology for over 40 years with a comprehensive product line including flame and graphite furnace atomic absorption (AA) spectrometers, inductively coupled plasma optical emission spectrometers (ICP-OES) and ICP-MS systems. The purchase of the remaining interest of the ICP-MS joint venture and related assets further solidifies PerkinElmer’s dedication to serving the needs of atomic spectroscopy laboratories across the globe.

Source:

PerkinElmer, Inc.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    PerkinElmer. (2019, June 19). PerkinElmer to purchase remaining interest of ICP-MS joint venture from Danaher. News-Medical. Retrieved on August 23, 2019 from https://www.news-medical.net/news/20100226/PerkinElmer-to-purchase-remaining-interest-of-ICP-MS-joint-venture-from-Danaher.aspx.

  • MLA

    PerkinElmer. "PerkinElmer to purchase remaining interest of ICP-MS joint venture from Danaher". News-Medical. 23 August 2019. <https://www.news-medical.net/news/20100226/PerkinElmer-to-purchase-remaining-interest-of-ICP-MS-joint-venture-from-Danaher.aspx>.

  • Chicago

    PerkinElmer. "PerkinElmer to purchase remaining interest of ICP-MS joint venture from Danaher". News-Medical. https://www.news-medical.net/news/20100226/PerkinElmer-to-purchase-remaining-interest-of-ICP-MS-joint-venture-from-Danaher.aspx. (accessed August 23, 2019).

  • Harvard

    PerkinElmer. 2019. PerkinElmer to purchase remaining interest of ICP-MS joint venture from Danaher. News-Medical, viewed 23 August 2019, https://www.news-medical.net/news/20100226/PerkinElmer-to-purchase-remaining-interest-of-ICP-MS-joint-venture-from-Danaher.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
PerkinElmer unveils CE-marked infectious disease immunoassays on EUROIMMUN random access instrument